Position in MDCX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,539
New position
Shares Held
243,362
first reported quarter
Ownership
0.385%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 23 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $46,000,026 across 13 Drug Manufacturers - General names. MDCX ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
834,735 | $20,100,418 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
68,150 | $8,610,071 | |
| 3 | LLY |
ELI LILLY & Co
|
6,991 | $8,385,215 | |
| 4 | NVO |
Novo Nordisk A S
|
48,420 | $2,321,254 | |
| 5 | GSK |
GSK plc
|
35,304 | $1,850,635 | |
| 6 | NVS |
Novartis AG
|
11,248 | $1,762,786 | |
| 7 | JNJ |
Johnson & Johnson
|
5,135 | $1,304,135 | |
| 8 | BIIB |
Biogen Inc.
|
3,239 | $699,818 |
All Filings in MDCX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,539 | 243,362 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||